Copyright Reports & Markets. All rights reserved.

Global Benign Prostatic Hyperplasia (BPH) Drugs Market Study 2016-2026, by Segment (Alpha-blocker, Phosphodiesterase Type-5 Inhibitors, … …), by Market (Hospitals, Clinics, … …), by Company (Astellas Pharma, Eli Lilly, … …)

Buy now

Table of Content

    1 Industry Overview

    • 1.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry
      • 1.1.1 Overview
      • 1.1.2 Products of Major Companies
    • 1.2 Market Segment
      • 1.2.1 Industry Chain
      • 1.2.2 Consumer Distribution
    • 1.3 Price & Cost Overview

    2 Benign Prostatic Hyperplasia (BPH) Drugs Market by Type

    • 2.1 By Type
      • 2.1.1 Alpha-blocker
      • 2.1.2 Phosphodiesterase Type-5 Inhibitors
      • 2.1.3 5-alpha-Reductase Inhibitors
    • 2.2 Market Size by Type
    • 2.3 Market Forecast by Type

    3 Global Market Demand

    • 3.1 Segment Overview
      • 3.1.1 Hospitals
      • 3.1.2 Clinics
      • 3.1.3 Others
    • 3.2 Market Size by Demand
    • 3.3 Market Forecast by Demand

    4 Major Region Market

    • 4.1 Global Market Overview
      • 4.1.1 Market Size & Growth
      • 4.1.2 Market Forecast
    • 4.2 Major Region
      • 4.2.1 Market Size & Growth
      • 4.2.2 Market Forecast

    5 Major Companies List

    • 5.1 Astellas Pharma (Company Profile, Sales Data etc.)
    • 5.2 Eli Lilly (Company Profile, Sales Data etc.)
    • 5.3 GlaxoSmithKline (Company Profile, Sales Data etc.)
    • 5.4 Sanofi (Company Profile, Sales Data etc.)
    • 5.5 ADC Therapeutics (Company Profile, Sales Data etc.)
    • 5.6 Bayer HealthCare (Company Profile, Sales Data etc.)
    • 5.7 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
    • 5.8 Valeant Pharmaceuticals (Company Profile, Sales Data etc.)
    • 5.9 Endo Pharmaceuticals (Company Profile, Sales Data etc.)
    • 5.10 Foresee Pharmaceuticals (Company Profile, Sales Data etc.)
    • 5.11 Madrigal Pharmaceuticals (Company Profile, Sales Data etc.)
    • 5.12 Merck (Company Profile, Sales Data etc.)
    • 5.13 Novartis (Company Profile, Sales Data etc.)
    • 5.14 Spectrum Pharmaceuticals (Company Profile, Sales Data etc.)
    • 5.15 Takeda Pharmaceuticals (Company Profile, Sales Data etc.)
    • 5.16 Teva (Company Profile, Sales Data etc.)
    • 5.17 Advaxis (Company Profile, Sales Data etc.)
    • 5.18 ANI Pharmaceuticals (Company Profile, Sales Data etc.)
    • 5.19 BHR Pharma (Company Profile, Sales Data etc.)

    6 Conclusion

      List of Tables

        List of Table

          Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2019, by Type, in USD Million

            Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2019, by Type, in Volume

              Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2020-2026, by Type, in USD Million

                Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2020-2026, by Type, in Volume

                  Table Global Benign Prostatic Hyperplasia (BPH) Drugs Demand 2016-2019, in USD Million

                    Table Global Benign Prostatic Hyperplasia (BPH) Drugs Demand 2016-2019, in Volume

                      Table Global Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2020-2026, in USD Million

                        Table Global Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2020-2026, in Volume

                          Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size & Growth 2016-2019, in USD Million

                            Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size & Growth 2016-2019, in Volume

                              Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2020-2026, in USD Million

                                Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2020-2026, in Volume

                                  Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2019, by Region, in USD Million

                                    Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2016-2019, by Region, in Volume

                                      Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2020-2026, by Region, in USD Million

                                        Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2020-2026, by Region, in Volume

                                          Table Astellas Pharma Overview List

                                            Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                              Table Astellas Pharma Overview List

                                                Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                  Table Eli Lilly Overview List

                                                    Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                      Table GlaxoSmithKline Overview List

                                                        Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                          Table Sanofi Overview List

                                                            Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                              Table ADC Therapeutics Overview List

                                                                Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ADC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                  Table Bayer HealthCare Overview List

                                                                    Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                      Table Bristol-Myers Squibb Overview List

                                                                        Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                          Table Valeant Pharmaceuticals Overview List

                                                                            Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                              Table Endo Pharmaceuticals Overview List

                                                                                Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                                  Table Foresee Pharmaceuticals Overview List

                                                                                    Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Foresee Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                                      Table Madrigal Pharmaceuticals Overview List

                                                                                        Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Madrigal Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                                          Table Merck Overview List

                                                                                            Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                                              Table Novartis Overview List

                                                                                                Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                                                  Table Spectrum Pharmaceuticals Overview List

                                                                                                    Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                                                      Table Takeda Pharmaceuticals Overview List

                                                                                                        Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Takeda Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                                                          Table Teva Overview List

                                                                                                            Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                                                              Table Advaxis Overview List

                                                                                                                Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Advaxis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                                                                  Table ANI Pharmaceuticals Overview List

                                                                                                                    Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ANI Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                                                                      Table BHR Pharma Overview List

                                                                                                                        Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of BHR Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

                                                                                                                          List of Figures

                                                                                                                            List of Figure

                                                                                                                              Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2016-2019, by Type, in USD Million

                                                                                                                                Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2016-2019, by Type, in Volume

                                                                                                                                Summary

                                                                                                                                The global Benign Prostatic Hyperplasia (BPH) Drugs market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
                                                                                                                                Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
                                                                                                                                Alpha-blocker
                                                                                                                                Phosphodiesterase Type-5 Inhibitors
                                                                                                                                5-alpha-Reductase Inhibitors
                                                                                                                                Demand Coverage (Market Size & Forecast, Consumer Distribution):
                                                                                                                                Hospitals
                                                                                                                                Clinics
                                                                                                                                Others
                                                                                                                                Company Coverage (Sales data, Main Products & Services etc.):
                                                                                                                                Astellas Pharma
                                                                                                                                Eli Lilly
                                                                                                                                GlaxoSmithKline
                                                                                                                                Sanofi
                                                                                                                                ADC Therapeutics
                                                                                                                                Bayer HealthCare
                                                                                                                                Bristol-Myers Squibb
                                                                                                                                Valeant Pharmaceuticals
                                                                                                                                Endo Pharmaceuticals
                                                                                                                                Foresee Pharmaceuticals
                                                                                                                                Madrigal Pharmaceuticals
                                                                                                                                Merck
                                                                                                                                Novartis
                                                                                                                                Spectrum Pharmaceuticals
                                                                                                                                Takeda Pharmaceuticals
                                                                                                                                Teva
                                                                                                                                Advaxis
                                                                                                                                ANI Pharmaceuticals
                                                                                                                                BHR Pharma
                                                                                                                                Major Region Market
                                                                                                                                North America
                                                                                                                                Europe
                                                                                                                                Asia-Pacific
                                                                                                                                South America
                                                                                                                                Middle East & Africa

                                                                                                                                Buy now